Markets & Regulations

(Image: Getty/Hakinmhan)

Roche suffers third delay on Spark deal

By Ben Hargreaves

Roche’s acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time.

Top ten stories of the month

Top ten stories of the month

By Ben Hargreaves

This month’s round-up of the most popular stories of the month, featuring a bold prediction of future growth for Chinese biotech and bad news for a potential treatment for Alzheimer’s disease.

Follow us

Products

View more

Webinars